Resuming elective hip and knee arthroplasty after the first phase of the SARS-CoV-2 pandemic: the European Hip Society and European Knee Associates recommendations - Summary - MDSpire

Resuming elective hip and knee arthroplasty after the first phase of the SARS-CoV-2 pandemic: the European Hip Society and European Knee Associates recommendations

  • By

  • N. P. Kort

  • E. Gómez Barrena

  • M. Bédard

  • S. Donell

  • J.-A. Epinette

  • B. Gomberg

  • M. T. Hirschmann

  • P. Indelli

  • Ismail Khosravi

  • T. Karachalios

  • M. C. Liebensteiner

  • B. Stuyts

  • R. Tandogan

  • B. Violante

  • L. Zagra

  • M. Thaler

  • August 25, 2020

  • 0 min

Share

Objective:

To provide recommendations for safely resuming elective hip and knee arthroplasty surgeries in the context of the ongoing SARS-CoV-2 pandemic.

Key Findings:
  • Delaying arthroplasty can lead to worse patient outcomes and increased healthcare costs.
  • New triage and patient selection criteria are necessary for resuming surgeries.
  • Outpatient procedures and enhanced recovery protocols are crucial in the current context.
  • Preoperative screening and tracking of patients and staff are essential.
  • Hospital ward modifications and enhanced disinfection protocols are recommended.
Interpretation:

The recommendations aim to balance the urgent need for elective surgeries with the safety of patients and healthcare workers during the ongoing pandemic.

Limitations:
  • The recommendations may evolve as new evidence emerges regarding SARS-CoV-2.
  • Variability in local healthcare resources and pandemic status may affect implementation, impacting patient access and safety.
Conclusion:

A structured approach is necessary for the safe resumption of elective hip and knee arthroplasties, considering both patient safety and healthcare system capacity, with ongoing evaluation as the situation evolves.

Original Source(s)

Related Content